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Previous work in our laboratory has shown that glutathione (GSH) availability is linked to cellular supply of ascorbic acid, through the
action of γ-glutamyltransferase (GGT). This enzyme activity is expressed in bronchial epithelia, and is also secreted in epithelial lining fluid.
We verified thus the possibility that GGT-mediated metabolism of glutathione may favour the supply of ascorbic acid to bronchial cells.
Using human BEAS-2B cells transfected with GGT cDNA, as well as WT cells exposed to ELF-like GGT concentrations, we observed that
indeed much higher (5–10 fold) levels of ascorbic acid are accumulated in the presence of GSH and active GGT. The data suggest that
administration of aerosolized GSH to CF patients may as well concur to sustain the vitamin C status of bronchial epithelia.
© 2007 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.Keywords: Airway inflamation; Oxidative stress; Epithetial lining fluid; Vitamin C supply; Glutathione; Gamma-glutamyltransferase1. Introduction
The production of oxidative damage to cells and tissues
during chronic lung inflammation is a well established
observation, e.g. in cystic fibrosis (CF), [1]. Accumulation of
neutrophils causes continued production of reactive oxygen
species. Lipoperoxidation is indicated by elevated concen-
trations of plasma malondialdehyde, breath pentane and
ethane and plasma hydroperoxides, as well as by depletion of
major lipoperoxidation substrates, such as linoleic and
arachidonic acids. Increased oxidative damage to DNA was
shown by elevated urinary concentrations of 8-hydroxygua-
nosine. Moreover, in stable CF patients elevated concentra-
tions were described of isoprostanes [2]. Consequence of
continued oxidative stress is progressive lung damage and
pulmonary fibrosis, being responsible for over 90% of the
observed mortality. In particular, in CF patients the problem⁎ Corresponding author. Department of Experimental Pathology, Univer-
sity of Pisa Medical School, Via Roma 55 - 56126 Pisa, Italy.
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doi:10.1016/j.jcf.2007.07.003is exacerbated by a deficiency in systemic antioxidant
activity partly due to malabsorption secondary to pancreatic
insufficiency, and antioxidant supplementation is therefore
recommended [2].
The importance of adequate levels of extracellular
antioxidants, i.e. those present in the lung epithelial lining
fluid (ELF), has been equally stressed. The major antioxidant
glutathione (GSH) is present at high concentrations in ELF,
where it can serve as a direct scavenger of prooxidant agents
produced during inflammation. Ascorbic acid (Vit. C) is
another important antioxidant in ELF [3], and its protective
effect against oxidative injury has been documented in type
II cells [4]. ELF compartment also contains significant levels
of γ-glutamyltransferase (GGT), but the function played by
this enzyme activity in pulmonary fluids remains to be
determined. Previous studies in our laboratory have shown
that GGT activity can give rise to prooxidant reactions with a
series of effects on cellular pathophysiology [5]), including
the oxidation of Vit. C to dehydroascorbic acid (DHA) [6].
Since – at variance with the reduced vitamin – DHA is
efficiently transported through GLUT transporters of the cell
membrane and is then reduced back to Vit. C by cellularuropean Cystic Fibrosis Society.
Table 2
Progressive release of active GGT enzyme protein in culture medium by
GGT-transfected BEAS-2B cells
Cells GGT activity (mU/mg cell protein)
48 h culture 72 h culture
WT ND 0.6±0.1
E1 (GGT-cDNA) 305.0±15.06 368.1±6.30
Values reported are means±SD of 3 independent determinations. ND, not
detectable.
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of Vit. C in ELF may facilitate cellular transport of vitamin C.
2. Materials and methods
2.1. Chemicals
Unless otherwise indicated, all reagents were from Sigma
Chemical Co. (Milan, Italy).
2.2. Cell culture and treatments
Human bronchial epithelial BEAS-2B cells were stable
transfected with a vector (pcDNA; Invitrogen) containing the
full-length cDNA of human GGT. A lipid transfection
according to Lipotaxi® mammalian transfection kit protocol
(Stratagene) was used and stable transfected clones, carrying
resistance to the antibiotic geneticin (G418), were selected.
At the end of procedures one clone with high GGT activity
(clone “E1”) and another, transfected with the empty vector
(clone “N7”) were selected and used for the subsequent
experiments. Transfected cells were routinely grown in
BEGM®medium (Cambrex, MD), supplemented with 2 mM
L-glutamine (L-Gln) and 0.2 μg/mL G418 (Invitrogen/Gibco,
Milan, Italy), at 37 °C in a 5%/95% CO2/air atmosphere.
Wild type cells were grown in the same medium in the
absence of G418.
For treatments, culture medium was replaced with Hank's
buffer, pH 7.4, containing ascorbic acid (60 μmol/L), GSH
(400 μmol/L), glycyl–glycine (4 mmol/L) and ADP-chelated
FeCl3 (100/10μmol/L, respectively).Where indicated, soluble
GGT (100 mU/mL) was added to incubation mixtures. Vit. C
concentrations were determined by high-pressure liquid
chromatography (HPLC) as described previously [6].
2.3. Other determinations
Determination of low molecular weight thiols was carried
out as described previously [7]. Briefly, cells were lysed in
TCA 5%, intracellular thiols were treated with 7-fluorobenzo-
2-oxa-1,3-diazole-4-sulfonate (SBD-F; Fluka) and their con-
centration was determined by a high-pressure liquid chroma-
tography system equipped with a C-18 reverse-phase column
(Resolve; Waters, USA) and a fluorimetric detector (RF-551;Table 1
GGT expression vs. intracellular levels of glutathione and cysteine after









WT (traces) 17.1±1.7 3.3±1.1
E1 (GGT-cDNA) 4.1±0.2 9.4±1.9 (*) 1.7±0.3 (**)
Values reported are means ±SD of 3 independent determinations.
(*) Pb.001. (**) Pb.01.Shimadzu, Japan). GSSG determinations were performed as
described previously [17].
For preparation of cell membrane and cytosolic fractions,
cell monolayers were collected in hypotonic lysis buffer
(10 mmol/LTris–HCl, pH 7.8), and cells were disrupted by a
tight-fitting glass–glass Dounce homogenizer (20 strokes).
Crude homogenates were centrifuged at 400 g (10 min, RT)
and then 100,000 g (60 min, 4 °C). The resulting supernatants
(cytosol) were collected, and the pellets (cell membranes)
were resuspended in hypotonic buffer. Both samples were
stored at −20 °C until GGT activity determinations.
GGT activity was determined spectrophotometrically
using γ-glutamyl-p-nitroanilide as substrate, as previously
described [5]. Incubation media were centrifuged at 10,000 g
(10 min, 4 °C) before GGT determinations.
Protein content was determined by the method of
Bradford (Bio-Rad® protein assay).
Statistical analysis of data was done using ANOVA with
Neuman–Keuls test for multiple comparisons.
3. Results
As compared to wild type cells, the GGT-transfected E1
clone presented with a high GGTactivity (4.1±0.2 U/mg cell
protein), while both WT and empty vector-transfected N7
cells showed only traces of enzyme activity (Table 1). When
the enzyme activity of E1 cells was separately determined,
2–3% of total expressed GGT activity was found in the
cytosolic fraction (data not shown). GGT-transfected cells
presented with a significant decrease (approx. 50%) in the
intracellular levels of both GSH and its precursor cysteine,
while no significant changes were appreciable in WT or N7
cells. The GSH decrease was not accounted for by oxidation
to GSSG, whose intracellular levels were not different in E1
as compared to WT cells (data not shown). E1 cells also
acquired the ability to release enzymatically active GGT
protein in the culture medium (Table 2); a substantial level of
soluble enzyme was detectable in medium at 48 h of culture,
and further increased with culture time.
Fig. 1 reports data concerning metabolism of extracellular
GSH and oxidation of Vit. C. GGT-transfected E1 cells were
capable of oxidizing Vit. C to DHA (Fig. 1B) while
metabolizing extracellular GSH (Fig. 1A), and this was
accompanied by a marked intracellular uptake of ascorbic
acid (Fig. 1E). No such effects were observed in WT cells
(Fig. 1C–D–E). In additional experiments, WT and sham-
176 A. Corti et al. / Journal of Cystic Fibrosis 7 (2008) 174–178transfected N7 cells were exposed to soluble GGT, added
exogenously at concentrations comparable with those found
in epithelial lining fluid (ELF) [8–10]. As expected, presence
of GGT activity in the medium caused GSH consumption
and Vit. C oxidation (not shown), as well as marked facili-
tation of Vit. C uptake in WT and N7 cells as well (Fig. 1E).Fig. 1. GGT activity facilitates cellular uptake of ascorbic acid in human bronc
transfected E1 cells, in basal conditions or conditions for “stimulated” GGT activity
(DHA) by E1 cells in the same incubations. GSH was added at final conc. of 40
(as acceptor for transpeptidation reaction; 4 mM). Incubation mixtures also containe
(6). Panels C, D: WT cells cannot consume extracellular GSH, nor oxidize Vit. C t
incubation. E1 cells achieved ascorbic acid levels approx. 10-fold higher than WT
likewise produced a marked increase of Vit. C (5-fold) in WT and sham-transfe
(*) Pb0.001 as compared to WT cells and N7 cells; (**) Pb0.001 as compared
different from WT.4. Discussion
The role played by γ-glutamyltransferase in airway
epithelia and epithelial lining fluids is not fully understood
yet. GGT catalyzes the first step in the degradation of
extracellular glutathione, i.e. the hydrolysis of the gamma-hial BEAS-2B cells. Panel A: metabolism of extracellular GSH by GGT-
(stim). Panel B: oxidation of ascorbic acid (Vit. C) to dehydroascorbic acid
0 μM. “Stimulation” of GGT was achieved by addition of glycyl–glycine
d ascorbic acid (60 μM) and ADP-chelated FeCl3 (100–10 μM, respectively)
o DHA. Panel E: intracellular accumulation of ascorbic acid after 30 min of
cells. Addition of soluble GGT at ELF-like concentration (100 mU/mL) (8)
cted N7 cells as well. Data are means±SD of three separate experiments.
to WT cells; (***) Pb0.001 as compared to N7 cells; ns, not significantly
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process GGT releases cysteinyl–glycine, which is subse-
quently cleaved to cysteine and glycine by plasma membrane
dipeptidase activities. Thus, GGT-mediated metabolism of
extracellular GSH provides cells with a means for the
recovery of cysteine, necessary for the intracellular resyn-
thesis of GSH. In this perspective, GGT can be seen as an
important factor in the maintenance of adequate antioxidant
defences within the cell; this likely explains why exposure to
prooxidant agents can induce the expression of GGT, as
shown e.g. in lung epithelial cells after challenge with a
sublethal oxidative stress [11]. Several studies have shown
however the ability of GGT to play a prooxidant role under
selected conditions, eventually leading to production of
reactive oxygen species (superoxide anion, hydrogen
peroxide), capable of stimulating prooxidant reactions. We
have previously characterized the details of biochemical
processes involved (reviewed in [12]), and described some
of the redox effects occurring at the cellular level, e.g. on
activation of transcription factors [13,14]. Data reported in
the present study confirm previous observations on GGT-
dependent prooxidant reactions. Intracellular GSH decrease,
such as reported in Table 1, is a known phenomenon in GGT-
transfected cells [15–17], and is likely the result of GSH
consumption caused by the low-level oxidative stress
imposed to cells by GGT activity itself [18]. The same
explanation can be invoked to explain the observed lower
levels of cysteine in E1 cells: extracellular reactions
promoted by GGT can favour the oxidation of cysteine to
cystine, whose cellular uptake is less efficient than that of
cysteine [19]. A minor percentage of transfected GGT
activity was detectable in the cytosolic fraction of E1 cells,
which raises the possibility that the observed GSH decrease
may actually result from GGT-mediated metabolism in the
cytosol. On the other hand, the possibility cannot be
excluded that some degree of contamination of cytosol
with GGT released from the cell membrane fraction may
have occurred during sample preparation procedures.
As an effect of oxidative processes mediated by GGT
activity in the extracellular space extracellular ascorbic acid
was oxidized by E1 bronchial cells to DHA, which resulted
in a favouring effect on cellular Vit. C status. The same
phenomenon was previously observed and characterized in
melanoma cells [6], and possibly represents an additional, as
yet unexplored role of GGT in extracellular spaces. GGT is
induced by oxidative stress in a wide range of cell types,
including type 2 pneumocytes [7]. It was reported that GGT
protein is released in ELF in conjunction with phosphatidyl-
choline of the surfactant [20], but the mechanisms
underlying such phenomenon remain unclear. As reported
in Table 2, GGT-transfected BEAS-2B cells become capable
of releasing GGT in the medium, and may thus represent a
suitable model to investigate this aspect. Interestingly, GGT
ELF concentrations were found to increase several fold in CF
patients, even if the mechanism underlying such increase
was not determined [21]. Increased expression and secretionof GGTwas generally interpreted in connection with its role
in metabolism of GSH and cellular thiol supply, as discussed
above. Our data in addition suggest that GGT secreted in
ELF may contribute to the maintenance of ascorbate-based
antioxidant defences in bronchial epithelial cells. From
levels of ≈20 mU/mL detectable in ELF of healthy subjects,
GGT activity is known to increase up to N100 mU/mL
during lung inflammation in CF patients (21). Indeed, our
data indicate that when exposed to exogenous GGT in the
same concentration range BEAS-2B cells do increase their
uptake of Vit. C (Fig. 1E).
On the other hand, the effect can take place provided that
sufficient levels of GSH are available in ELF, such to sustain
enzyme activity. CF patients actually present with decreased
levels of glutathione, likely due to increased consumption
during inflammation-related oxidative stress [22]. Moreover,
it has been proposed that GSH deficiency in CF ELF may
derive – at least in part – from the same alterations in CFTR
channel which originate the disease, leading to abnormal
GSH transport across the membranes of epithelial cells
[9,23]. CF patients also present with decreased levels of
ascorbic acid [24]. Altogether, regardless the cause under-
lying depletion of ELF GSH in CF patients, it is conceivable
that current attempts to reconstitute such levels by
administration of aerosolized buffered GSH may also
produce indirect, beneficial effects on the ascorbic acid
status of airway epithelia, contributing to reinforcement of
cellular antioxidant defences.
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